Global Viral Gene Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 90

Published Date: 16 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Viral Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Viral Gene Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Viral Gene Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Viral Gene Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Integrating Viral Vectors
    Non-Integrating Viral Vectors

Market segment by Application, can be divided into
    Metabolic Diseases
    Cardiovascular Diseases
    Muscular Diseases
    Hematologic Diseases
    Ophthalmologic Diseases
    Infectious Diseases
    Others

Market segment by players, this report covers
    Lonza
    Biogen
    Catalent
    Gilead Sciences
    Sarepta Therapeutics
    Novartis
    Amgen
    Ionis Pharmaceuticals
    Spark Therapeutics
    Shanghai Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Viral Gene Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Viral Gene Therapy, with revenue, gross margin and global market share of Viral Gene Therapy from 2019 to 2021.
Chapter 3, the Viral Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Viral Gene Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Viral Gene Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Viral Gene Therapy
    1.2 Classification of Viral Gene Therapy by Type
        1.2.1 Overview: Global Viral Gene Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Viral Gene Therapy Revenue Market Share by Type in 2020
        1.2.3 Integrating Viral Vectors
        1.2.4 Non-Integrating Viral Vectors
    1.3 Global Viral Gene Therapy Market by Application
        1.3.1 Overview: Global Viral Gene Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Metabolic Diseases
        1.3.3 Cardiovascular Diseases
        1.3.4 Muscular Diseases
        1.3.5 Hematologic Diseases
        1.3.6 Ophthalmologic Diseases
        1.3.7 Infectious Diseases
        1.3.8 Others
    1.4 Global Viral Gene Therapy Market Size & Forecast
    1.5 Global Viral Gene Therapy Market Size and Forecast by Region
        1.5.1 Global Viral Gene Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Viral Gene Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Viral Gene Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Viral Gene Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Viral Gene Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Viral Gene Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Viral Gene Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Viral Gene Therapy Market Drivers
        1.6.2 Viral Gene Therapy Market Restraints
        1.6.3 Viral Gene Therapy Trends Analysis

2 Company Profiles
    2.1 Lonza
        2.1.1 Lonza Details
        2.1.2 Lonza Major Business
        2.1.3 Lonza Viral Gene Therapy Product and Solutions
        2.1.4 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Lonza Recent Developments and Future Plans
    2.2 Biogen
        2.2.1 Biogen Details
        2.2.2 Biogen Major Business
        2.2.3 Biogen Viral Gene Therapy Product and Solutions
        2.2.4 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Biogen Recent Developments and Future Plans
    2.3 Catalent
        2.3.1 Catalent Details
        2.3.2 Catalent Major Business
        2.3.3 Catalent Viral Gene Therapy Product and Solutions
        2.3.4 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Catalent Recent Developments and Future Plans
    2.4 Gilead Sciences
        2.4.1 Gilead Sciences Details
        2.4.2 Gilead Sciences Major Business
        2.4.3 Gilead Sciences Viral Gene Therapy Product and Solutions
        2.4.4 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Gilead Sciences Recent Developments and Future Plans
    2.5 Sarepta Therapeutics
        2.5.1 Sarepta Therapeutics Details
        2.5.2 Sarepta Therapeutics Major Business
        2.5.3 Sarepta Therapeutics Viral Gene Therapy Product and Solutions
        2.5.4 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Viral Gene Therapy Product and Solutions
        2.6.4 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Amgen
        2.7.1 Amgen Details
        2.7.2 Amgen Major Business
        2.7.3 Amgen Viral Gene Therapy Product and Solutions
        2.7.4 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Amgen Recent Developments and Future Plans
    2.8 Ionis Pharmaceuticals
        2.8.1 Ionis Pharmaceuticals Details
        2.8.2 Ionis Pharmaceuticals Major Business
        2.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product and Solutions
        2.8.4 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Ionis Pharmaceuticals Recent Developments and Future Plans
    2.9 Spark Therapeutics
        2.9.1 Spark Therapeutics Details
        2.9.2 Spark Therapeutics Major Business
        2.9.3 Spark Therapeutics Viral Gene Therapy Product and Solutions
        2.9.4 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Spark Therapeutics Recent Developments and Future Plans
    2.10 Shanghai Sunway Biotech
        2.10.1 Shanghai Sunway Biotech Details
        2.10.2 Shanghai Sunway Biotech Major Business
        2.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product and Solutions
        2.10.4 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Shanghai Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Viral Gene Therapy Product and Solutions
        2.11.4 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Viral Gene Therapy Product and Solutions
        2.12.4 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Viral Gene Therapy Product and Solutions
        2.13.4 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Viral Gene Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Viral Gene Therapy Players Market Share
        3.2.2 Top 10 Viral Gene Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Viral Gene Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Viral Gene Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Viral Gene Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Viral Gene Therapy Revenue Market Share by Application (2016-2021)
    5.2 Viral Gene Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Viral Gene Therapy Revenue by Type (2016-2026)
    6.2 North America Viral Gene Therapy Revenue by Application (2016-2026)
    6.3 North America Viral Gene Therapy Market Size by Country
        6.3.1 North America Viral Gene Therapy Revenue by Country (2016-2026)
        6.3.2 United States Viral Gene Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Viral Gene Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Viral Gene Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Viral Gene Therapy Revenue by Type (2016-2026)
    7.2 Europe Viral Gene Therapy Revenue by Application (2016-2026)
    7.3 Europe Viral Gene Therapy Market Size by Country
        7.3.1 Europe Viral Gene Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Viral Gene Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Viral Gene Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Viral Gene Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Viral Gene Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Viral Gene Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Viral Gene Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Viral Gene Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Viral Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Viral Gene Therapy Revenue by Region (2016-2026)
        8.3.2 China Viral Gene Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Viral Gene Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Viral Gene Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Viral Gene Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Viral Gene Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Viral Gene Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Viral Gene Therapy Revenue by Type (2016-2026)
    9.2 South America Viral Gene Therapy Revenue by Application (2016-2026)
    9.3 South America Viral Gene Therapy Market Size by Country
        9.3.1 South America Viral Gene Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Viral Gene Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Viral Gene Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Viral Gene Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Viral Gene Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Viral Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Viral Gene Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Viral Gene Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Viral Gene Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Viral Gene Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Viral Gene Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Viral Gene Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Viral Gene Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Viral Gene Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Viral Gene Therapy Revenue Market Share by Region (2021-2026)
    Table 6. Lonza Corporate Information, Head Office, and Major Competitors
    Table 7. Lonza Major Business
    Table 8. Lonza Viral Gene Therapy Product and Solutions
    Table 9. Lonza Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Biogen Corporate Information, Head Office, and Major Competitors
    Table 11. Biogen Major Business
    Table 12. Biogen Viral Gene Therapy Product and Solutions
    Table 13. Biogen Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Catalent Corporate Information, Head Office, and Major Competitors
    Table 15. Catalent Major Business
    Table 16. Catalent Viral Gene Therapy Product and Solutions
    Table 17. Catalent Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Gilead Sciences Corporate Information, Head Office, and Major Competitors
    Table 19. Gilead Sciences Major Business
    Table 20. Gilead Sciences Viral Gene Therapy Product and Solutions
    Table 21. Gilead Sciences Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 23. Sarepta Therapeutics Major Business
    Table 24. Sarepta Therapeutics Viral Gene Therapy Product and Solutions
    Table 25. Sarepta Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Novartis Corporate Information, Head Office, and Major Competitors
    Table 27. Novartis Major Business
    Table 28. Novartis Viral Gene Therapy Product and Solutions
    Table 29. Novartis Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Amgen Corporate Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Viral Gene Therapy Product and Solutions
    Table 33. Amgen Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Ionis Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 35. Ionis Pharmaceuticals Major Business
    Table 36. Ionis Pharmaceuticals Viral Gene Therapy Product and Solutions
    Table 37. Ionis Pharmaceuticals Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Spark Therapeutics Major Business
    Table 40. Spark Therapeutics Viral Gene Therapy Product and Solutions
    Table 41. Spark Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Shanghai Sunway Biotech Corporate Information, Head Office, and Major Competitors
    Table 43. Shanghai Sunway Biotech Major Business
    Table 44. Shanghai Sunway Biotech Viral Gene Therapy Product and Solutions
    Table 45. Shanghai Sunway Biotech Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. SIBIONO Corporate Information, Head Office, and Major Competitors
    Table 47. SIBIONO Major Business
    Table 48. SIBIONO Viral Gene Therapy Product and Solutions
    Table 49. SIBIONO Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. AnGes Corporate Information, Head Office, and Major Competitors
    Table 51. AnGes Major Business
    Table 52. AnGes Viral Gene Therapy Product and Solutions
    Table 53. AnGes Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 55. Orchard Therapeutics Major Business
    Table 56. Orchard Therapeutics Viral Gene Therapy Product and Solutions
    Table 57. Orchard Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Global Viral Gene Therapy Revenue (USD Million) by Players (2019-2021)
    Table 59. Global Viral Gene Therapy Revenue Share by Players (2019-2021)
    Table 60. Breakdown of Viral Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. Viral Gene Therapy Players Head Office, Products and Services Provided
    Table 62. Viral Gene Therapy Mergers & Acquisitions in the Past Five Years
    Table 63. Viral Gene Therapy New Entrants and Expansion Plans
    Table 64. Global Viral Gene Therapy Revenue (USD Million) by Type (2016-2021)
    Table 65. Global Viral Gene Therapy Revenue Share by Type (2016-2021)
    Table 66. Global Viral Gene Therapy Revenue Forecast by Type (2021-2026)
    Table 67. Global Viral Gene Therapy Revenue by Application (2016-2021)
    Table 68. Global Viral Gene Therapy Revenue Forecast by Application (2021-2026)
    Table 69. North America Viral Gene Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 70. North America Viral Gene Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 71. North America Viral Gene Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 72. North America Viral Gene Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 73. North America Viral Gene Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 74. North America Viral Gene Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 75. Europe Viral Gene Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 76. Europe Viral Gene Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 77. Europe Viral Gene Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 78. Europe Viral Gene Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 79. Europe Viral Gene Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 80. Europe Viral Gene Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 81. Asia-Pacific Viral Gene Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 82. Asia-Pacific Viral Gene Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 83. Asia-Pacific Viral Gene Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 84. Asia-Pacific Viral Gene Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Viral Gene Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Viral Gene Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 87. South America Viral Gene Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 88. South America Viral Gene Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 89. South America Viral Gene Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 90. South America Viral Gene Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 91. South America Viral Gene Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 92. South America Viral Gene Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 93. Middle East & Africa Viral Gene Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 94. Middle East & Africa Viral Gene Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 95. Middle East & Africa Viral Gene Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 96. Middle East & Africa Viral Gene Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Viral Gene Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Viral Gene Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Viral Gene Therapy Picture
    Figure 2. Global Viral Gene Therapy Revenue Market Share by Type in 2020
    Figure 3. Integrating Viral Vectors
    Figure 4. Non-Integrating Viral Vectors
    Figure 5. Viral Gene Therapy Revenue Market Share by Application in 2020
    Figure 6. Metabolic Diseases Picture
    Figure 7. Cardiovascular Diseases Picture
    Figure 8. Muscular Diseases Picture
    Figure 9. Hematologic Diseases Picture
    Figure 10. Ophthalmologic Diseases Picture
    Figure 11. Infectious Diseases Picture
    Figure 12. Others Picture
    Figure 13. Global Viral Gene Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global Viral Gene Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Viral Gene Therapy Revenue Market Share by Region (2016-2026)
    Figure 16. Global Viral Gene Therapy Revenue Market Share by Region in 2020
    Figure 17. North America Viral Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe Viral Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific Viral Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America Viral Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa Viral Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Viral Gene Therapy Market Drivers
    Figure 23. Viral Gene Therapy Market Restraints
    Figure 24. Viral Gene Therapy Market Trends
    Figure 25. Lonza Recent Developments and Future Plans
    Figure 26. Biogen Recent Developments and Future Plans
    Figure 27. Catalent Recent Developments and Future Plans
    Figure 28. Gilead Sciences Recent Developments and Future Plans
    Figure 29. Sarepta Therapeutics Recent Developments and Future Plans
    Figure 30. Novartis Recent Developments and Future Plans
    Figure 31. Amgen Recent Developments and Future Plans
    Figure 32. Ionis Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Spark Therapeutics Recent Developments and Future Plans
    Figure 34. Shanghai Sunway Biotech Recent Developments and Future Plans
    Figure 35. SIBIONO Recent Developments and Future Plans
    Figure 36. AnGes Recent Developments and Future Plans
    Figure 37. Orchard Therapeutics Recent Developments and Future Plans
    Figure 38. Global Viral Gene Therapy Revenue Share by Players in 2020
    Figure 39. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 40. Global Top 3 Players Viral Gene Therapy Revenue Market Share in 2020
    Figure 41. Global Top 10 Players Viral Gene Therapy Revenue Market Share in 2020
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 43. Global Viral Gene Therapy Revenue Share by Type in 2020
    Figure 44. Global Viral Gene Therapy Market Share Forecast by Type (2021-2026)
    Figure 45. Global Viral Gene Therapy Revenue Share by Application in 2020
    Figure 46. Global Viral Gene Therapy Market Share Forecast by Application (2021-2026)
    Figure 47. North America Viral Gene Therapy Sales Market Share by Type (2016-2026)
    Figure 48. North America Viral Gene Therapy Sales Market Share by Application (2016-2026)
    Figure 49. North America Viral Gene Therapy Revenue Market Share by Country (2016-2026)
    Figure 50. United States Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Canada Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Mexico Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Europe Viral Gene Therapy Sales Market Share by Type (2016-2026)
    Figure 54. Europe Viral Gene Therapy Sales Market Share by Application (2016-2026)
    Figure 55. Europe Viral Gene Therapy Revenue Market Share by Country (2016-2026)
    Figure 56. Germany Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. France Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. United Kingdom Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Russia Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Italy Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Asia-Pacific Viral Gene Therapy Sales Market Share by Type (2016-2026)
    Figure 62. Asia-Pacific Viral Gene Therapy Sales Market Share by Application (2016-2026)
    Figure 63. Asia-Pacific Viral Gene Therapy Revenue Market Share by Region (2016-2026)
    Figure 64. China Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Japan Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South Korea Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. India Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Southeast Asia Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Australia Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South America Viral Gene Therapy Sales Market Share by Type (2016-2026)
    Figure 71. South America Viral Gene Therapy Sales Market Share by Application (2016-2026)
    Figure 72. South America Viral Gene Therapy Revenue Market Share by Country (2016-2026)
    Figure 73. Brazil Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Argentina Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Middle East and Africa Viral Gene Therapy Sales Market Share by Type (2016-2026)
    Figure 76. Middle East and Africa Viral Gene Therapy Sales Market Share by Application (2016-2026)
    Figure 77. Middle East and Africa Viral Gene Therapy Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Saudi Arabia Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. UAE Viral Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics

Related Reports

Global Viral Gene Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Viral Gene Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Pharma & Healthcare

The Viral Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Viral Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Viral Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 30 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Viral Gene Therapy market size was valued at USD 7305.5 million in 2022 and is forecast to a readjusted size of USD 21600 million by 2029 with a CAGR of 16.7% during review period.

Global Viral Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Viral Gene Therapy Supply, Demand and Key Producers, 2023-2029

date 30 Aug 2023

date Pharma & Healthcare

The global Viral Gene Therapy market size is expected to reach $ 21600 million by 2029, rising at a market growth of 16.7% CAGR during the forecast period (2023-2029).

Global Viral Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Viral Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Viral Gene Therapy market size was valued at USD 7305.5 million in 2023 and is forecast to a readjusted size of USD 21600 million by 2030 with a CAGR of 16.7% during review period.

Global Viral Gene Therapy Supply, Demand and Key Producers, 2024-2030

Global Viral Gene Therapy Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Viral Gene Therapy market size is expected to reach $ 21600 million by 2030, rising at a market growth of 16.7% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>